Detalles de la búsqueda
1.
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.
Ann Oncol
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755096
2.
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant.
Breast Cancer Res
; 25(1): 103, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653397
3.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Ann Oncol
; 33(12): 1250-1268, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228963
4.
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study.
Ann Oncol
; 31(5): 569-581, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32278621
5.
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group.
Ann Oncol
; 31(2): 246-256, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959341
6.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Ann Oncol
; 31(4): 451-469, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32081575
7.
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer.
Ann Oncol
; 30(4): 558-566, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30689707
8.
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases.
Ann Oncol
; 29(3): 669-680, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29342248
9.
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors.
Ann Oncol
; 28(4): 855-861, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28119295
10.
Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment.
Ann Oncol
; 28(1): 110-115, 2017 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27687309
11.
Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
Osteoporos Int
; 28(4): 1413-1422, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28083668
12.
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.
Ann Oncol
; 32(12): 1475-1495, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34678411
13.
Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.
Br J Cancer
; 112(1): 103-11, 2015 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25349977
14.
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study.
Br J Cancer
; 110(4): 967-75, 2014 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-24457912
15.
Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer.
Br J Surg
; 101(12): 1560-5, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25200278
16.
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial.
ESMO Open
; 9(5): 102924, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38796287
17.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer.
ESMO Open
; 9(5): 102974, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38796284
18.
Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
Br J Cancer
; 108(10): 1978-84, 2013 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23652310
19.
The beneficial effect of palliative resection in metastatic colorectal cancer.
Br J Cancer
; 108(7): 1425-31, 2013 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23481187
20.
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer.
Ann Oncol
; 24(10): 2630-2635, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23868905